FSA
BEAT

Franklin Street Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Franklin Street Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-14,500
Closed -$236K – 210
2016
Q2 		$236K Sell
14,500
-8,200
-36% -$121K 0.04% 171
2016
Q1 		$265K Buy
22,700
+600
+3% +$6.7K 0.05% 190
2015
Q4 		$258K Buy
22,100
+9,450
+75% +$120K 0.05% 182
2015
Q3 		$155K Buy
+12,650
New +$161K 0.03% 211

Other funds holding BEAT

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Franklin Street Advisors's BEAT Position: Q3 2016 in Review

Franklin Street Advisors sold out of BioTelemetry, Inc. (BEAT) in Q3 2016, closing a stake of 14,500 shares — an estimated $236K sold.

Franklin Street Advisors first reported a position in BEAT in Q3 2015 and held it in 4 quarters. The position peaked at $265K in Q1 2016. 167 funds tracked by Wall St. Rank hold BEAT as of Q3 2016.

  • Franklin Street Advisors reported no remaining BioTelemetry, Inc. position as of Q3 2016 after selling out during the quarter.
  • Franklin Street Advisors sold 14,500 BioTelemetry, Inc. shares in Q3 2016, an estimated $236K.
  • Franklin Street Advisors first reported a position in BioTelemetry, Inc. in Q3 2015 and held it in 4 quarters.
  • Franklin Street Advisors's BioTelemetry, Inc. position peaked at $265K in Q1 2016.
  • 167 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2016.

Based on Franklin Street Advisors's 13F filing for Q3 2016, filed 5 Oct 2016.